Clinical trials
Recruiting Phase 1 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 17 |
| 2025 | 15 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Eli Lilly and Company | 3 |
| National Cancer Institute (NCI) | 3 |
| AbbVie | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| NiKang Therapeutics, Inc. | 2 |
| A&G Pharmaceutical Inc. | 1 |
| Ahmad Shariftabrizi | 1 |
| Aktis Oncology, Inc. | 1 |
| Alison Stopeck | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 64 |
| Carcinoma, Non-Small-Cell Lung | 29 |
| Breast Neoplasms | 22 |
| Squamous Cell Carcinoma of Head and Neck | 17 |
| Colorectal Neoplasms | 16 |
| Endometrial Neoplasms | 13 |
| Neoplasm Metastasis | 11 |
| Ovarian Neoplasms | 11 |
| Stomach Neoplasms | 11 |
| Uterine Cervical Neoplasms | 10 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.